Breast Surgery Evidence-Based Literature Review 2023-2024

---

RSSAAPACMECNE

Occurs monthly on the 4th Monday starting on 2/6/2023 at 4:30 PM
Monday, February 6, 2023, 4:30 PM - 5:30 PM, Virtual, Philadelphia, PA

Evidence-based literature review provides faculty, residents, advanced practice providers, and nurses a forum to review the most updated peer-reviewed literature related to benign and malignant breast disease to facilitate adherence to evolving contemporary clinical practice guidelines.

1. Discuss and critically evaluate recently published practice-changing, peer-reviewed literature
2. Describe new trends and therapeutic modalities in breast surgery
3. Discuss and evaluate the nuanced application of research finding into clinical practice scenarios
4. Describe how to identify barriers that prevent direct integration of scientific findings into daily patient care

In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

Designation of Credit
Physicians: Penn Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance / Participation (1.00 hours), NCPD Hours (ANCC) (1.00 hours), American Academy of Physician Assistants (1.00 hours)

Mitigation of Relevant Financial Relationships

Penn Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

No faculty are available for this activity at this time.

Date	Empty Column	Title
3/27/2023 4:30:00 PM	Breast Surgery Evidence-Based Literature Review 2023-2024 - 3/27/2023 Role of Neoadujuvant Therapy for HR+ Breast Cancer 3/27/2023 4:30:00 PM 3/27/2023 5:30:00 PM 15 False MM/DD/YYYY	Breast Surgery Evidence-Based Literature Review 2023-2024 - 3/27/2023 Role of Neoadujuvant Therapy for HR+ Breast Cancer Evidence-based literature review provides faculty, residents, advanced practice providers, and nurses a forum to review the most updated peer-reviewed literature related to benign and malignant breast disease to facilitate adherence to evolving contemporary clinical practice guidelines. Objective(s): 1 Discuss general principles of pre-operative therapy 2 Describe the significance of pathologic complete in HR+ breast cancer and the average response rates 3 Describe neoadjuvant chemotherapy or endocrine therapy Location: Specialties: DIAGNOSTIC RADIOLOGY, INTERNAL MEDICINE - Medical Oncology, RADIATION ONCOLOGY, SURGERY, SURGERY - Complex General Surgical Oncology Faculty Disclosures: Saveri Bhattacharya, DO (Consulting Fee-Pfizer, Inc. (Relationship has ended) - 06/06/2022) Download Handout Credits: AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance / Participation (1.00 hours), NCPD Hours (ANCC) (1.00 hours), American Academy of Physician Assistants (1.00 hours) Specialties: DIAGNOSTIC RADIOLOGY, INTERNAL MEDICINE - Medical Oncology, RADIATION ONCOLOGY, SURGERY, SURGERY - Complex General Surgical Oncology